Laurel Wealth Advisors LLC Astrazeneca PLC Transaction History
Laurel Wealth Advisors LLC
- $6.97 Billion
- Q2 2025
A detailed history of Laurel Wealth Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Laurel Wealth Advisors LLC holds 26,205 shares of AZN stock, worth $2.16 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
26,205
Previous 375
6888.0%
Holding current value
$2.16 Million
Previous $27,000
1288.89%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,449Shares Held
489MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.28 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.39 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.83 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.59 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.57 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $255B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...